The use of sofosbuvir for the treatment of recurrent hepatitis C after liver transplantation
The article presents the experience of direct-acting antiviral (DAA) drug treatment for hepatitis C in the patients after liver transplantation. The end-stage liver disease caused by hepatitis C is the main indication for orthotopic liver transplantation (OLT). In 2013, the first agent in the class...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
N.V. Sklifosovsky Research Institute for Emergency Medicine of Moscow Healthcare Department
2017-03-01
|
| Series: | Transplantologiâ |
| Subjects: | |
| Online Access: | https://www.jtransplantologiya.ru/jour/article/view/150 |